Home
Tai Sandi See, Chief Development Officer: Lexeo Therapeutics LXEO Sell · Filed 25/10/17
Trade details
- Type
- Insider sale
- Amount
- $34,365.36
- Shares · price
- 3,844 sh · $8.94 a share
- Held after
- 65,906 sh
- Trade date
- 25/10/17
- Filed
- 25/10/17
- Days to filing
- 0 days
Sold 5.5% of holdings
- Share of holding sold
- 5.5%
Lexeo Therapeutics trades, last 26 weeks
What else happened in Lexeo Therapeutics around then
Filed or reported within 30 days of the trade day · 25/09/17~25/11/16Tai Sandi See's recent trades
- Tai Sandi See
Planned saleLexeo Therapeutics
Planned saleLexeo Therapeutics
LXEO
$24.7K
3,861 sh
$24.7K
Filed 02/18
Traded 02/18
- Tai Sandi See
SellLexeo Therapeutics
SellLexeo Therapeutics
LXEO
$3,578
386 sh
$3,578
Filed 25/11/20
Traded 25/11/18
- Tai Sandi See
Planned saleLexeo Therapeutics
Planned saleLexeo Therapeutics
LXEO
$3,580
386 sh
$3,580
Filed 25/11/18
Traded 25/11/18
- Tai Sandi See
SellLexeo Therapeutics
SellLexeo Therapeutics
LXEO
$421
44 sh
$421
Filed 25/10/17
Traded 25/10/17
- Tai Sandi See
Planned saleLexeo Therapeutics
Planned saleLexeo Therapeutics
LXEO
$34.8K
3,888 sh
$34.8K
Filed 25/10/17
Traded 25/10/17